Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma the rando Published Date November 6, 2025 Long, Georgina V, et al. Nature Medicine 2025 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen